2CEO image
Deposition Date 2006-02-08
Release Date 2006-08-14
Last Version Date 2023-12-13
Entry Detail
PDB ID:
2CEO
Keywords:
Title:
thyroxine-binding globulin complex with thyroxine
Biological Source:
Source Organism:
HOMO SAPIENS (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
2.80 Å
R-Value Free:
0.28
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:THYROXINE-BINDING GLOBULIN
Gene (Uniprot):SERPINA7
Chain IDs:A, B
Chain Length:379
Number of Molecules:2
Biological Source:HOMO SAPIENS
Primary Citation
Structural Mechanism for the Carriage and Release of Thyroxine in the Blood.
Proc.Natl.Acad.Sci.USA 103 13321 ? (2006)
PMID: 16938877 DOI: 10.1073/PNAS.0604080103

Abstact

The hormones that most directly control tissue activities in health and disease are delivered by two noninhibitory members of the serpin family of protease inhibitors, thyroxine-binding globulin (TBG) and corticosteroid-binding globulin. The structure of TBG bound to tetra-iodo thyroxine, solved here at 2.8 A, shows how the thyroxine is carried in a surface pocket on the molecule. This unexpected binding site is confirmed by mutations associated with a loss of hormone binding in both TBG and also homologously in corticosteroid-binding globulin. TBG strikingly differs from other serpins in having the upper half of its main beta-sheet fully opened, so its reactive center peptide loop can readily move in and out of the sheet to give an equilibrated binding and release of thyroxine. The entry of the loop triggers a conformational change, with a linked contraction of the binding pocket and release of the bound thyroxine. The ready reversibility of this change is due to the unique presence in the reactive loop of TBG of a proline that impedes the full and irreversible entry of the loop that occurs in other serpins. Thus, TBG has adapted the serpin inhibitory mechanism to give a reversible flip-flop transition, from a high-affinity to a low-affinity form. The complexity and ready triggering of this conformational mechanism strongly indicates that TBG has evolved to allow a modulated and targeted delivery of thyroxine to the tissues.

Legend

Protein

Chemical

Disease

Primary Citation of related structures